118 related articles for article (PubMed ID: 3162139)
1. [Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Ronco E; Pilliot J
Pathol Biol (Paris); 1985 May; 33(5):381-4. PubMed ID: 3162139
[TBL] [Abstract][Full Text] [Related]
2. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
Ishag AJ; Durgham SM; Shibl AM
Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
[TBL] [Abstract][Full Text] [Related]
5. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
Dabernat H; Delmas C; Lareng MB
Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pefloxacin.
Husson MO; Izard D; Bouillet L; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
[TBL] [Abstract][Full Text] [Related]
9. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
Croize J; Le Noc P; Bryskier A; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activity of norfloxacin, ofloxacin and ciprofloxacin according to resistance phenotypes to nalidixic acid and pefloxacin].
Soussy CJ; Le Van Thoi J; Duval J
Pathol Biol (Paris); 1990 May; 38(5):376-84. PubMed ID: 2367152
[TBL] [Abstract][Full Text] [Related]
13. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Berardi-Grassias LD; Roy O
Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
[TBL] [Abstract][Full Text] [Related]
15. [Influence of technical factors in the determination of minimal inhibitory concentration by microdilution].
Forey F; Coulet M; Brun Y; Fleurette J
Pathol Biol (Paris); 1985 May; 33(5):341-9. PubMed ID: 3162138
[TBL] [Abstract][Full Text] [Related]
16. Determination of MICs for staphylococci using the API ATB quinolone and API ATB macrolide systems.
Rohner P; Peyret M; Auckenthaler R
Pathol Biol (Paris); 1993 Apr; 41(4):323-8. PubMed ID: 8233630
[TBL] [Abstract][Full Text] [Related]
17. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
Watanabe S; Ito T; Hiramatsu K
J Antimicrob Chemother; 2007 Dec; 60(6):1384-7. PubMed ID: 17890283
[TBL] [Abstract][Full Text] [Related]
18. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
19. A comparison of disc agar diffusion and agar dilution for the detection of methicillin resistant staphylococci.
Diller DL; Flournoy DJ
Methods Find Exp Clin Pharmacol; 1988 Nov; 10(11):695-7. PubMed ID: 3221741
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Husson MO; Izard D; Leclerc H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
